Century Communities Celebrates Grand Opening in Puyallup, WA

Ribbon-cutting ceremony marks launch of new home sales and model home tours Century Communities, Inc.-a top 10 national homebuilder, industry leader in online home sales, and the highest-ranked homebuilder on Newsweek's list of America's Most Trustworthy Companies 2025-announced Heritage Heights, the company's new community in Puyallup, WA, hosted a ribbon-cutting ceremony on June 13 with […]

IOVA DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Iovance Biotherapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – IOVA

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) between May 9, 2024 and May 8, 2025, both dates inclusive (the "Class Period"), of the important July 14, 2025 lead plaintiff deadline. SO WHAT:

L’ORÉAL PARIS ANNOUNCES CHARLOTTE CARDIN AS NEWEST AMBASSADOR IN CANADA AND FRANCE

L'Oréal Paris Canada is proud to announce award-winning Canadian singer-songwriter Charlotte Cardin as its newest ambassador. She's known for her soulful vocals, introspective lyrics, and blend of pop, jazz, and electronic influences. In 2024, 99 NIGHTS won Album of the year at the Juno Award and later that year she made history as Billboard Canada

Bronstein, Gewirtz & Grossman, LLC Encourages Quantum Corporation (QMCO) Investors to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quantum Corporation ("Quantum" or "the Company") (NASDAQ:QMCO). Investors who purchased Quantum securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/QMCO. Investigation Details

Recover Investment Losses: Levi & Korsinsky Files Class Action Against 3D Systems Corporation (DDD)

NEW YORK, NY / ACCESS Newswire / July 2, 2025 / If you suffered a loss on your 3D Systems Corporation (NYSE:DDD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/3d-systems-corporation-lawsuit-submission-form?prid=155322&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Young America Capital Advises Climber in Strategic Acquisition by Revenue Analytics, Expanding AI Revenue Management for the Hospitality Industry

Young America Capital (“YAC”), a leading middle-market investment bank and FINRA-registered broker-dealer, is pleased to announce its role as exclusive financial advisor to Climber, a provider of AI-powered hotel revenue management software, in its acquisition by Revenue Analytics, a global pricing technology company. This strategic transaction expands the combined companies' ability to deliver advanced pricing

CEO Confidence Continues to Cool in Q2 2025 as Hiring Plans Hit an All-Time Low

Vistage's Small and Midsize Business CEO Survey Reveals Economic Uncertainty Is Adding to Business Leaders' Burnout Small and midsize business (SMB) CEOs' confidence in the economy continued to edge down in Q2 2025, according to the latest CEO Confidence Index from CEO coaching and peer advisory organization Vistage. https://mma.prnewswire.com/media/2723224/Vistage_Worldwide_Logo.jpg The Index dipped to 77.2 in

OXLUMO® (lumasiran injection) Now Reimbursed in Canada For the Treatment of Primary Hyperoxaluria Type 1 (PH1) in Pediatric and Adult Patients

OXLUMO has been shown to significantly reduce urinary oxalate, which drives the progression of PH1 Disease1 Alnylam Canada ULC is pleased to announce that OXLUMO® (lumasiran) is now funded across Canada through both public and private plans. OXLUMO is an RNA interference (RNAi) therapeutic administered via subcutaneous injection, indicated for the treatment of primary hyperoxaluria

WST DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 7 Deadline in Securities Class Action – WST

NEW YORK CITY, NY / ACCESS Newswire / July 2, 2025 / WHY: New York, N.Y., July 2, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE:WST) between February 16, 2023 and February 12, 2025, both dates inclusive (the "Class Period"), of the

Scroll to Top